Distinct and opposite effects of leukemogenic Idh and Tet2 mutations in hematopoietic stem and progenitor cells Journal Article


Authors: Fortin, J.; Chiang, M. F.; Meydan, C.; Foox, J.; Ramachandran, P.; Leca, J.; Lemonnier, F.; Li, W. Y.; Gams, M. S.; Sakamoto, T.; Chu, M.; Tobin, C.; Laugesen, E.; Robinson, T. M.; You-Ten, A.; Butler, D. J.; Berger, T.; Minden, M. D.; Levine, R. L.; Guidos, C. J.; Melnick, A. M.; Mason, C. E.; Mak, T. W.
Article Title: Distinct and opposite effects of leukemogenic Idh and Tet2 mutations in hematopoietic stem and progenitor cells
Abstract: Mutations in IDH1,IDH2, and TET2 are recurrently observed in myeloid neoplasms. IDH1 and IDH2 encode isocitrate dehydrogenase isoforms, which normally catalyze the conversion of isocitrate to α-ketoglutarate (α-KG). Oncogenic IDH1/2 mutations confer neomorphic activity, leading to the production of D-2-hydroxyglutarate (D-2-HG), a potent inhibitor of α-KG-dependent enzymes which include the TET methylcytosine dioxygenases. Given their mutual exclusivity in myeloid neoplasms, IDH1, IDH2, and TET2 mutations may converge on a common oncogenic mechanism. Contrary to this expectation, we observed that they have distinct, and even opposite, effects on hematopoietic stem and progenitor cells in genetically engineered mice. Epigenetic and single-cell transcriptomic analyses revealed that Idh2R172K and Tet2 loss-of-function have divergent consequences on the expression and activity of key hematopoietic and leukemogenic regulators. Notably, chromatin accessibility and transcriptional deregulation in Idh2R172K cells were partially disconnected from DNA methylation alterations. These results highlight unanticipated divergent effects of IDH1/2 and TET2 mutations, providing support for the optimization of genotype-specific therapies.
Keywords: epigenetics; idh; tet2; myeloid neoplasm
Journal Title: Proceedings of the National Academy of Sciences of the United States of America
Volume: 120
Issue: 4
ISSN: 0027-8424
Publisher: National Academy of Sciences  
Date Published: 2023-01-24
Start Page: e2208176120
Language: English
DOI: 10.1073/pnas.2208176120
PUBMED: 36652477
PROVIDER: scopus
PMCID: PMC9942850
DOI/URL:
Notes: Article -- Export Date: 1 February 2023 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ross Levine
    775 Levine